TransMedics Group, Inc. Fair Value Adjustment of Warrants
TransMedics Group, Inc. (TMDX) reported Fair Value Adjustment of Warrants of $0 for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-03-11
- TransMedics Group, Inc. fair value adjustment of warrants for the quarter ending 2020-09-30 was $0.00.
- TransMedics Group, Inc. fair value adjustment of warrants for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- TransMedics Group, Inc. fair value adjustment of warrants for the quarter ending 2020-03-31 was $0.00.
- TransMedics Group, Inc. fair value adjustment of warrants for the quarter ending 2019-12-28 was $0.00.
- TransMedics Group, Inc. fair value adjustment of warrants for fiscal 2019 was $341.00K, a 37.43% decline from fiscal 2018.
- TransMedics Group, Inc. fair value adjustment of warrants for fiscal 2018 was $545.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $0.00 derived: sum of 3 quarters · filed 2020-11-06 | $0.00 derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-07 | $0.00 derived: sum of 2 quarters · filed 2020-08-07 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $0.00 derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $614.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $614.00K derived: sum of 3 quarters · filed 2021-03-11 | $341.00K 10-K · filed 2021-03-11 |
| 2019-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $614.00K derived: sum of 2 quarters · filed 2020-08-07 | $341.00K 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $614.00K 10-Q · filed 2020-08-07 | $341.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | -$273.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $545.00K 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $183.00K 10-Q · filed 2019-11-08 | $393.00K derived: sum of 2 quarters · filed 2019-11-08 | $423.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $210.00K 10-Q · filed 2019-08-08 | $240.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $30.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |